furosemide and warfarin

furosemide has been researched along with warfarin in 68 studies

Research

Studies (68)

Timeframe	Studies, this research(%)	All Research%
pre-1990	14 (20.59)	18.7374
1990's	10 (14.71)	18.2507
2000's	18 (26.47)	29.6817
2010's	24 (35.29)	24.3611
2020's	2 (2.94)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Faller, B; Wohnsland, F	1
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL	1
Caron, G; Ermondi, G	1
Jolivette, LJ; Ward, KW	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Lombardo, F; Obach, RS; Waters, NJ	1
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM	1
He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Sun, Y; Yan, Z	1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM	1
Botta, M; Dreassi, E; Falchi, F; Maga, G; Santucci, A; Schenone, S; Zizzari, AT	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W	1
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S	1
Conradi, R; Lee, PH; Shanmugasundaram, V	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Avdeef, A; Tam, KY	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Gozalbes, R; Pineda-Lucena, A	1
Ekins, S; Williams, AJ; Xu, JJ	1
Buttar, D; Colclough, N; Gerhardt, S; MacFaul, PA; Maskos, K; Phillips, SD; Plowright, A; Steinbacher, S; Steuber, H; Tam, K; Whittamore, P	1
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A	1
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K	1
Honda, K; Izumi, T; Miyaji, Y; Nakayama, S; Okazaki, O; Okudaira, N; Shiosakai, K; Sugiyama, D; Suzuki, W; Takakusa, H; Watanabe, A	1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR	1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y	1
Bajusz, D; Balogh, GT; Dargó, G; Müller, J; Simon, K	1
Sebille, B; Thuaud, N; Tillement, JP	2
Andreasen, F; Foged, L; Husted, S	1
Emery, H; Hall, JG; Shaul, WL	1
Higuchi, M; Itoh, N; Miyasaka, M; Moriya, T; Nakazawa, K; Oguchi, H; Shigematsu, H	1
Brater, DC; Kirchner, KA; Voelker, JR	1
Johnston, A; Ravic, M; Turner, P	1
Sakai, H	1
Chaumeil, JC; Decroix, MO; Tillement, JP; Zini, R	1
Neill, P	1
Buu-Hoï, NP; Hieu, HT; Hoï, TT	1
Kenmure, AC	1
Kuhnz, W; Luck, W; Nau, H; Wegener, S	1
Burke, W; DePace, NL; Glazier, EE; Kotler, MN	1
D'Arcy, PF	1
Iwaki, M; Konishi, Y; Ogiso, T	1
Barre, J; Campos, H; d'Athis, P; Prandota, J; Tillement, JP	1
Hundt, HK; Luus, HG; Schall, R	1
Haruta, A; Kodama, H; Otagiri, M; Suenaga, A; Takamura, N; Tsuruoka, M; Yamasaki, K	1
Huang, CR; Nikolic, D; van Breemen, RB; Venton, DL; Woodbury, CP; Zhao, YZ	1
Cyr, M; Laizure, SC; Madlock, L; Self, T	1
Erim, FB; Kraak, JC	1
du Souich, P; Geadah, D; Pichette, V	1
Demirbag, R; Eryonucu, B; Gül, A; Güler, N	1
Sei, Y; Seki, H; Shikii, K; Shimotakahara, S; Tashiro, M; Utsumi, H; Yamaguchi, K	1
Kawai, K; Nishii, R; Nishio, T; Takamura, N; Tokunaga, J; Yoshimoto, M	1
Marison, IW; von Stockar, U; Whelehan, M	1
Gorski, JC; Lindamood, C; Ortiz, S; Rackley, R; Shaw, A	1
Islam, S; Kim, DY; Mondal, NT; Mussell, F; Rauchholz, M	1
Chedgy, F; Howlett, DC; Inglis, C	1
Chong, E; Kalia, V; Willsie, S; Winkle, P	1
Cheng, F; Fadli, Z; Huang, H; Lu, Y; Nagar, C; Pietsch, M; Shen, D; Tu, YC	1
Adam, AM; Ali Mallick, MS; Godil, A; Khan, F; Makhdoom, IM; Rizvi, AH	1
Biyani, K; Guttendorf, R; Klaerner, G; Lee, A; Li, E; Mathur, V; Parsell, D; Shao, J; Stasiv, Y; Tabakman, S; Tsao, L; Wu, YS	1

Reviews

2 review(s) available for furosemide and warfarin

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Clinical pharmacological studies of some possible interactions of lornoxicam with other drugs. Postgraduate medical journal, 1990, Volume: 66 Suppl 4 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Digoxin; Drug Interactions; Furosemide; Glyburide; Humans; Male; Piroxicam; Warfarin	1990

Trials

3 trial(s) available for furosemide and warfarin

Article	Year
Influences of haemodialysis on the binding sites of human serum albumin: possibility of an efficacious administration plan using binding inhibition. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2008, Volume: 23, Issue:7 Topics: Adult; Aged; Barbiturates; Binding Sites; Carbon Radioisotopes; Diazepam; Diuretics; Fatty Acids, Nonesterified; Female; Furans; Furosemide; Hippurates; Humans; Indican; Kidney Failure, Chronic; Male; Middle Aged; Propionates; Protein Binding; Renal Dialysis; Serum Albumin; Treatment Outcome; Warfarin	2008
Drug-drug interactions between sucroferric oxyhydroxide and losartan, furosemide, omeprazole, digoxin and warfarin in healthy subjects. Journal of nephrology, 2014, Volume: 27, Issue:6 Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Anticoagulants; Area Under Curve; Cardiotonic Agents; Chelating Agents; Digoxin; Diuretics; Drug Administration Schedule; Drug Combinations; Drug Interactions; Female; Ferric Compounds; Furosemide; Half-Life; Healthy Volunteers; Humans; Losartan; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Models, Statistical; Omeprazole; Proton Pump Inhibitors; Risk Assessment; Sucrose; Warfarin; Young Adult	2014
Assessment of the Potential for Veverimer Drug-Drug Interactions. Drug metabolism and disposition: the biological fate of chemicals, 2021, Volume: 49, Issue:7 Topics: Absorption, Physicochemical; Acidosis; Administration, Oral; Adolescent; Adult; Aspirin; Cross-Over Studies; Dabigatran; Drug Interactions; Ethacrynic Acid; Female; Furosemide; Gastrointestinal Absorption; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Polymers; Polypharmacy; Renal Insufficiency, Chronic; Solubility; Warfarin; Young Adult	2021

Other Studies

63 other study(ies) available for furosemide and warfarin

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes. Journal of medicinal chemistry, 2001, Mar-15, Volume: 44, Issue:6 Topics: Alkanes; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Membranes, Artificial; Octanols; Permeability; Pharmaceutical Preparations; Solubility; Water	2001
Cheminformatic models to predict binding affinities to human serum albumin. Journal of medicinal chemistry, 2001, Dec-06, Volume: 44, Issue:25 Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids	2001
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk). Journal of medicinal chemistry, 2005, May-05, Volume: 48, Issue:9 Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water	2005
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure. Journal of pharmaceutical sciences, 2005, Volume: 94, Issue:7 Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution	2005
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2). Journal of medicinal chemistry, 2008, Jun-12, Volume: 51, Issue:11 Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship	2008
First-principle, structure-based prediction of hepatic metabolic clearance values in human. European journal of medicinal chemistry, 2009, Volume: 44, Issue:4 Topics: Computational Biology; Drug Discovery; Hepatocytes; Humans; Hydrogen-Ion Concentration; Liver; Metabolic Clearance Rate; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship; Sensitivity and Specificity; Software	2009
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1. Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19 Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship	2008
Determination of permeability and lipophilicity of pyrazolo-pyrimidine tyrosine kinase inhibitors and correlation with biological data. European journal of medicinal chemistry, 2009, Volume: 44, Issue:9 Topics: Humans; Lipids; Membranes, Artificial; Permeability; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-abl; Pyrazoles; Pyrimidines	2009
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data. European journal of medicinal chemistry, 2009, Volume: 44, Issue:11 Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution	2009
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain. Bioorganic & medicinal chemistry, 2009, Oct-01, Volume: 17, Issue:19 Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship	2009
Development of an in silico model for human skin permeation based on a Franz cell skin permeability assay. Bioorganic & medicinal chemistry letters, 2010, Jan-01, Volume: 20, Issue:1 Topics: 1-Methyl-3-isobutylxanthine; Cell Line; Cell Membrane Permeability; Humans; Models, Biological; Quantitative Structure-Activity Relationship; Skin Absorption	2010
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability? Journal of medicinal chemistry, 2010, May-13, Volume: 53, Issue:9 Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis	2010
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
QSAR-based solubility model for drug-like compounds. Bioorganic & medicinal chemistry, 2010, Oct-01, Volume: 18, Issue:19 Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
A combined spectroscopic and crystallographic approach to probing drug-human serum albumin interactions. Bioorganic & medicinal chemistry, 2010, Nov-01, Volume: 18, Issue:21 Topics: Binding Sites; Crystallography, X-Ray; Drug Interactions; Humans; Pharmaceutical Preparations; Protein Binding; Protein Structure, Tertiary; Serum Albumin; Spectrometry, Fluorescence	2010
Prediction of drug intestinal absorption by new linear and non-linear QSPR. European journal of medicinal chemistry, 2011, Volume: 46, Issue:1 Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics	2011
QSAR-based permeability model for drug-like compounds. Bioorganic & medicinal chemistry, 2011, Apr-15, Volume: 19, Issue:8 Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2011
Combination of GSH trapping and time-dependent inhibition assays as a predictive method of drugs generating highly reactive metabolites. Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:7 Topics: Glutathione; Pharmacology; Sulfur Radioisotopes	2011
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions. Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10 Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection	2012
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship	2012
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships. Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16 Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone	2016
Human Serum Albumin Binding in a Vial: A Novel UV-pH Titration Method To Assist Drug Design. Journal of medicinal chemistry, 2020, 02-27, Volume: 63, Issue:4 Topics: Binding Sites; Chemistry, Pharmaceutical; Drug Design; Humans; Hydrogen-Ion Concentration; Molecular Docking Simulation; Pharmaceutical Preparations; Protein Binding; Serum Albumin, Human; Spectrophotometry, Ultraviolet; Titrimetry	2020
Study of binding of low-molecular-weight ligand to biological macromolecules by high-performance liquid chromatography. Evaluation of binding parameters for two drugs bound to human serum albumin. Journal of chromatography, 1978, Dec-21, Volume: 167 Topics: Chromatography, High Pressure Liquid; Furosemide; Humans; Kinetics; Ligands; Protein Binding; Serum Albumin; Spectrophotometry, Ultraviolet; Warfarin	1978
Protein binding of phenprocoumon in the absence and presence of furosemide. Acta pharmacologica et toxicologica, 1976, Volume: 39, Issue:3 Topics: Coumarins; Drug Interactions; Fluorometry; Furosemide; Humans; Phenprocoumon; Protein Binding; Serum Albumin	1976
Chondrodysplasia punctata and maternal warfarin use during pregnancy. American journal of diseases of children (1960), 1975, Volume: 129, Issue:3 Topics: Abnormalities, Drug-Induced; Alcoholism; Cerebrovascular Disorders; Chondrodysplasia Punctata; Contraceptives, Oral; Diazepam; Female; Fetus; Furosemide; Humans; Hypertension; Infant, Newborn; Male; Pregnancy; Pregnancy Complications; Radiography; Rheumatic Heart Disease; Stress, Psychological; Warfarin	1975
A case of IgA nephritis showing diffuse podocytic detachment from the glomerular basement membrane. Nihon Jinzo Gakkai shi, 1992, Volume: 34, Issue:4 Topics: Adolescent; Basement Membrane; Cyclophosphamide; Dipyridamole; Drug Therapy, Combination; Female; Furosemide; Glomerulonephritis, IGA; Glomerulonephritis, Membranoproliferative; Humans; Kidney Glomerulus; Prednisolone; Warfarin	1992
Binding inhibitors restore furosemide potency in tubule fluid containing albumin. Kidney international, 1991, Volume: 40, Issue:3 Topics: Albumins; Animals; Binding Sites; Binding, Competitive; Body Fluids; Dansyl Compounds; Drug Tolerance; Furosemide; Kidney Tubules, Distal; Male; Nephrotic Syndrome; Perfusion; Protein Binding; Rats; Rats, Inbred Strains; Sarcosine; Sulfisoxazole; Warfarin	1991
[Treatment of glomerulonephritis]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1990, Feb-10, Volume: 79, Issue:2 Topics: Cyclophosphamide; Digitalis; Furosemide; Glomerulonephritis; Humans; Nephrotic Syndrome; Plants, Medicinal; Plants, Toxic; Prednisolone; Warfarin	1990
Cefazolin serum protein binding and its inhibition by bilirubin, fatty acids and other drugs. Biochemical pharmacology, 1988, Jul-15, Volume: 37, Issue:14 Topics: Bilirubin; Blood Proteins; Cefazolin; Fatty Acids, Nonesterified; Furosemide; Humans; In Vitro Techniques; Protein Binding; Serum Albumin; Tolbutamide; Warfarin	1988
Axillary vein thrombosis complicating peripartum congestive cardiomyopathy. The Central African journal of medicine, 1987, Volume: 33, Issue:12 Topics: Adult; Axillary Vein; Cardiomyopathy, Dilated; Female; Follow-Up Studies; Furosemide; Heparin; Humans; Potassium; Pregnancy; Puerperal Disorders; Thrombosis; Time Factors; Warfarin	1987
Dialogue: Complications of aortic valve replacement. Postgraduate medicine, 1974, Volume: 56, Issue:1 Topics: Anti-Bacterial Agents; Aortic Valve; Aspergillosis; Bacterial Infections; Calcinosis; Diagnosis, Differential; Embolism; Endocarditis; Furosemide; Heart Auscultation; Heart Valve Prosthesis; Heparin; Humans; Kidney; Lanatosides; Leg; Male; Middle Aged; Morphine; Myocardial Infarction; Myocardium; Oxygen; Postoperative Complications; Renal Artery; Thrombosis; Tooth Extraction; Warfarin	1974
[Effects of different diuretics on the anticoagulant power of antivitamin K in rats; relations between chemical structure and its effects]. Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D: Sciences naturelles, 1969, Mar-10, Volume: 268, Issue:10 Topics: Androstanes; Animals; Anticoagulants; Blood Coagulation Factors; Chlorthalidone; Diuretics; Drug Antagonism; Drug Synergism; Ethyl Biscoumacetate; Furosemide; Male; Rats; Warfarin	1969
Pregnancy in a patient with a prosthetic mitral valve. The Journal of obstetrics and gynaecology of the British Commonwealth, 1968, Volume: 75, Issue:5 Topics: Adult; Chlorpropamide; Digoxin; Female; Fetal Death; Furosemide; Gestational Age; Heart Valve Prosthesis; Humans; Mitral Valve Stenosis; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy in Diabetics; Warfarin	1968
Serum protein binding of diazepam, desmethyldiazepam, furosemide, indomethacin, warfarin, and phenobarbital in human fetus, mother, and newborn infant. Pediatric pharmacology (New York, N.Y.), 1983, Volume: 3, Issue:3-4 Topics: Blood Proteins; Diazepam; Fatty Acids, Nonesterified; Female; Fetal Blood; Furosemide; Humans; Indomethacin; Infant, Newborn; Maternal-Fetal Exchange; Nordazepam; Phenobarbital; Pregnancy; Protein Binding; Warfarin	1983
An unusual case of Bjork-Shiley mitral valve dysfunction corrected nonsurgically. Chest, 1981, Volume: 80, Issue:4 Topics: Aspirin; Cardiomegaly; Dipyridamole; Echocardiography; Female; Furosemide; Heart Murmurs; Heart Valve Prosthesis; Humans; Hypotension; Middle Aged; Mitral Valve Prolapse; Phenylephrine; Prothrombin Time; Warfarin	1981
Early reports on drug interactions. Drug intelligence & clinical pharmacy, 1983, Volume: 17, Issue:2 Topics: Acetaminophen; Amiodarone; Apazone; Aspirin; Carbamazepine; Chlordiazepoxide; Cimetidine; Coumarins; Drug Interactions; Erythromycin; Ethanol; Furosemide; Gentamicins; Humans; Levodopa; Lidocaine; Phenytoin; Prenylamine; Quinidine	1983
Effect of furosemide on plasma clearance, anticoagulant effect and protein binding of warfarin in rats. Journal of pharmacobio-dynamics, 1982, Volume: 5, Issue:10 Topics: Administration, Oral; Animals; Drug Interactions; Fatty Acids, Nonesterified; Furosemide; Injections, Intravenous; Liver; Male; Potassium; Protein Binding; Prothrombin; Rats; Rats, Inbred Strains; Serum Albumin, Bovine; Sodium; Warfarin	1982
Retention data methods for the determination of drug-protein binding parameters by high-performance liquid chromatography. Journal of chromatography, 1981, Jan-16, Volume: 204 Topics: Chromatography, High Pressure Liquid; Furosemide; Humans; Kinetics; Mathematics; Phenylbutazone; Serum Albumin; Warfarin	1981
Binding of erythromycin base to human plasma proteins. The Journal of international medical research, 1980, Volume: 8 Suppl 2 Topics: Aspirin; Bilirubin; Blood Proteins; Erythromycin; Furosemide; Humans; Hydrogen-Ion Concentration; Orosomucoid; Phenylbutazone; Protein Binding; Serum Albumin; Temperature; Warfarin	1980
Pharmacokinetic characteristics for extent of absorption and clearance in drug/drug interaction studies. International journal of clinical pharmacology and therapeutics, 1994, Volume: 32, Issue:12 Topics: Absorption; Drug Interactions; Furosemide; Half-Life; Humans; Metabolic Clearance Rate; Pharmacokinetics; Ranitidine; Therapeutic Equivalency; Warfarin	1994
Mode of interaction of loop diuretics with human serum albumin and characterization of binding site. Pharmaceutical research, 1996, Volume: 13, Issue:7 Topics: Binding Sites; Diuretics; Fluorescent Dyes; Furosemide; Humans; Ibuprofen; Lysine; Protein Binding; Serum Albumin; Sulfonamides; Warfarin	1996
Pulsed ultrafiltration mass spectrometry: a new method for screening combinatorial libraries. Analytical chemistry, 1997, Jun-01, Volume: 69, Issue:11 Topics: Adenine; Adenosine Deaminase; Animals; Cattle; Drug Design; Enzyme Inhibitors; Furosemide; Humans; Intestines; Ligands; Mass Spectrometry; Methanol; Molecular Weight; Online Systems; Pulsatile Flow; Salicylates; Salicylic Acid; Serum Albumin; Thyroxine; Ultrafiltration; Warfarin	1997
Decreased hypoprothrombinemic effect of warfarin associated with furosemide. Therapeutic drug monitoring, 1997, Volume: 19, Issue:3 Topics: Anticoagulants; Blood Coagulation; Diuresis; Diuretics; Dose-Response Relationship, Drug; Drug Interactions; Furosemide; Humans; Male; Middle Aged; Prothrombin; Warfarin	1997
Vacancy affinity capillary electrophoresis to study competitive protein-drug binding. Journal of chromatography. B, Biomedical sciences and applications, 1998, Jun-12, Volume: 710, Issue:1-2 Topics: Animals; Binding, Competitive; Cattle; Electrophoresis, Capillary; Evaluation Studies as Topic; Furosemide; Pharmaceutical Preparations; Phenylbutazone; Protein Binding; Serum Albumin; Warfarin	1998
Role of plasma protein binding on renal metabolism and dynamics of furosemide in the rabbit. Drug metabolism and disposition: the biological fate of chemicals, 1999, Volume: 27, Issue:1 Topics: Animals; Anticoagulants; Area Under Curve; Biological Availability; Blood Pressure; Diuretics; Furosemide; Glomerular Filtration Rate; Half-Life; Kidney; Male; Metabolic Clearance Rate; Protein Binding; Rabbits; Serum Albumin; Warfarin	1999
A case of successful six consecutive deliveries in a 41-year-old woman with Uhl's anomaly. International journal of cardiology, 2003, Volume: 87, Issue:2-3 Topics: Angiotensin-Converting Enzyme Inhibitors; Drug Therapy, Combination; Echocardiography, Transesophageal; Female; Furosemide; Gestational Age; Heart Defects, Congenital; Heart Failure; Heart Ventricles; Humans; Parity; Pregnancy; Pregnancy Outcome; Pregnancy, High-Risk; Ventricular Dysfunction, Right; Warfarin	2003
Application of difference NOE-pumping NMR technique and cold-spray ionization mass spectrometry to identify a ligand binding with a protein receptor. Analytical sciences : the international journal of the Japan Society for Analytical Chemistry, 2004, Volume: 20, Issue:10 Topics: Furosemide; Humans; Ligands; Nuclear Magnetic Resonance, Biomolecular; Protein Binding; Salicylic Acid; Serum Albumin; Spectrometry, Mass, Electrospray Ionization; Temperature; Warfarin	2004
Removal of pharmaceuticals from water: using liquid-core microcapsules as a novel approach. Water research, 2010, Volume: 44, Issue:7 Topics: Capsules; Carbamazepine; Clofibric Acid; Diclofenac; Environmental Monitoring; Feasibility Studies; Fresh Water; Furosemide; Kinetics; Metoprolol; Pharmaceutical Preparations; Reproducibility of Results; Sulfamethoxazole; Warfarin; Water Pollutants, Chemical; Water Purification; Water Supply	2010
Effects of commonly administered agents and genetics on nebivolol pharmacokinetics: drug-drug interaction studies. Journal of clinical pharmacology, 2011, Volume: 51, Issue:4 Topics: Adult; Antihypertensive Agents; Benzopyrans; Cytochrome P-450 CYP2D6; Digoxin; Drug Interactions; Ethanolamines; Female; Fluoxetine; Furosemide; Genotype; Humans; Hydrochlorothiazide; Losartan; Male; Middle Aged; Nebivolol; Ramipril; Warfarin; Young Adult	2011
Biventricular thrombi associated with peripartum cardiomyopathy. Journal of health, population, and nutrition, 2011, Volume: 29, Issue:2 Topics: Bangladesh; Cardiomyopathies; Drug Combinations; Echocardiography; Enalapril; Female; Furosemide; Humans; Peripartum Period; Puerperal Disorders; Thrombosis; Ventricular Dysfunction, Left; Warfarin; Young Adult	2011
A case of recurrent ventricular tachycardia. BMJ (Clinical research ed.), 2011, Jun-01, Volume: 342 Topics: Aged; Atorvastatin; Cardiovascular Agents; Digoxin; Drug Therapy, Combination; Female; Furosemide; Heptanoic Acids; Humans; Isosorbide Dinitrate; Lisinopril; Nitroglycerin; Pyrroles; Recurrence; Tachycardia, Ventricular; Warfarin	2011
A novel algorithm for analyzing drug-drug interactions from MEDLINE literature. Scientific reports, 2015, Nov-27, Volume: 5 Topics: Algorithms; Contraindications; Drug Interactions; Enzymes; Furosemide; Humans; Hydrolysis; Ibuprofen; MEDLINE; Sertraline; Warfarin	2015
Lutembacher syndrome with mitral valve calcification in a 31-year old male. JPMA. The Journal of the Pakistan Medical Association, 2018, Volume: 68, Issue:2 Topics: Adrenergic beta-Antagonists; Adult; Amiloride; Anticoagulants; Atrial Fibrillation; Bundle-Branch Block; Calcinosis; Cardiac Surgical Procedures; Cardiomegaly; Cyanosis; Diuretics; Echocardiography; Edema; Electrocardiography; Foot; Furosemide; Heart Septal Defects, Atrial; Humans; Lutembacher Syndrome; Male; Mitral Valve Annuloplasty; Mitral Valve Stenosis; Tricuspid Valve Insufficiency; Warfarin	2018